https://nepalhealthcaretimes.com/article/908282227-oruka-therapeutics-to-host-conference-call-to-report-week-16-data-for-orka-001-from-the-ongoing-everlast-a-trial-on-april-27-2026 Nepal Healthcare Times en PressRelease 2026-04-26T16:00:00+00:00 Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026 https://ml.globenewswire.com/media/3950d2d7-850d-459a-9e42-07c642a841c5/small/oruka-full-color-jpg.jpg https://nepalhealthcaretimes.com/article/908279678-c3-davos-of-healthcare-silicon-valley-summit-opens-tomorrow-in-sunnyvale-with-kfsh Nepal Healthcare Times en PressRelease 2026-04-26T15:50:00+00:00 C3 Davos of Healthcare™ Silicon Valley Summit Opens Tomorrow in Sunnyvale with KFSH https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://nepalhealthcaretimes.com/article/908279684-c3-davos-of-healthcare-silicon-valley-summit-tem-in-cio-amanh-em-sunnyvale-com-a-presen-a-do-kfsh Nepal Healthcare Times en PressRelease 2026-04-26T15:50:00+00:00 C3 Davos of Healthcare™ Silicon Valley Summit Tem Início Amanhã em Sunnyvale com a Presença do KFSH https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://nepalhealthcaretimes.com/article/908279687-el-c3-davos-of-healthcare-silicon-valley-summit-se-inaugura-ma-ana-en-sunnyvale-con-kfsh Nepal Healthcare Times en PressRelease 2026-04-26T15:50:00+00:00 El C3 Davos of Healthcare™ Silicon Valley Summit se inaugura mañana en Sunnyvale con KFSH https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://nepalhealthcaretimes.com/article/908179975-heroup-claims-evaluated-investigating-the-supplement-facts-about-hero-up-capsules-for-hardero-male-enhancement-support Nepal Healthcare Times en PressRelease 2026-04-26T01:13:17+00:00 HeroUp Claims Evaluated: Investigating the Supplement Facts About Hero Up Capsules for Hardero Male Enhancement Support https://zingfast.com/wp-content/uploads/2026/04/HeroUp-Male-Enhancement.jpg https://nepalhealthcaretimes.com/article/908160348-quad-ed-under-investigation-safe-clinician-prescribed-ed-medication-using-sildenafil-tadalafil-vardenafil-and-apomorphine-for-men Nepal Healthcare Times en PressRelease 2026-04-25T22:24:56+00:00 Quad ED Under Investigation: Safe Clinician-Prescribed ED Medication Using Sildenafil, Tadalafil, Vardenafil and Apomorphine for Men https://zingfast.com/wp-content/uploads/2026/04/Quad-ED.jpg https://nepalhealthcaretimes.com/article/908132022-healthrx-blood-support-claims-evaluated-the-health-rx-blood-pressure-optimizer-formula-under-investigation Nepal Healthcare Times en PressRelease 2026-04-25T19:10:06+00:00 HealthRX Blood Support Claims Evaluated: The Health RX Blood Pressure Optimizer Formula Under Investigation https://zingfast.com/wp-content/uploads/2026/04/Health-RX-Blood-Pressure-Optimizer-Formula.jpg https://nepalhealthcaretimes.com/article/908097107-study-shows-implicity-s-new-agnostic-cloud-based-ai-algorithm-further-reduces-false-alerts-even-after-manufacturer-ai-filtering-in-modern-devices Nepal Healthcare Times en PressRelease 2026-04-25T15:00:00+00:00 Study Shows Implicity’s New Agnostic Cloud-Based AI Algorithm Further Reduces False Alerts Even After Manufacturer AI Filtering in Modern Devices https://ml.globenewswire.com/media/d7822800-7d4d-420d-aa7f-89a50a370756/small/implicity-logo-jpg.jpg https://nepalhealthcaretimes.com/article/908094243-kfsh-advances-precision-surgery-through-in-house-3d-printing-program Nepal Healthcare Times en PressRelease 2026-04-25T14:45:00+00:00 KFSH Advances Precision Surgery Through In-House 3D Printing Program https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://nepalhealthcaretimes.com/article/908094260-kfsh-avanza-en-la-cirug-a-de-precisi-n-mediante-un-programa-interno-de-impresi-n-3d Nepal Healthcare Times en PressRelease 2026-04-25T14:45:00+00:00 KFSH avanza en la cirugía de precisión mediante un programa interno de impresión 3D https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://nepalhealthcaretimes.com/article/908094264-kfsh-avan-a-na-cirurgia-de-precis-o-com-o-programa-interno-de-impress-o-3d Nepal Healthcare Times en PressRelease 2026-04-25T14:45:00+00:00 KFSH Avança na Cirurgia de Precisão Com o Programa Interno de Impressão 3D https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://nepalhealthcaretimes.com/article/907954581-kfsh-ampl-a-la-medicina-gen-mica-desde-la-investigaci-n-hasta-la-toma-de-decisiones-cl-nicas Nepal Healthcare Times en PressRelease 2026-04-25T02:27:10+00:00 KFSH amplía la medicina genómica desde la investigación hasta la toma de decisiones clínicas https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://nepalhealthcaretimes.com/article/907954626-kfsh-expande-a-medicina-gen-mica-da-pesquisa-para-a-tomada-de-decis-o-cl-nica Nepal Healthcare Times en PressRelease 2026-04-25T02:27:10+00:00 KFSH Expande a Medicina Genômica da Pesquisa para a Tomada de Decisão Clínica https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://nepalhealthcaretimes.com/article/907937662-alpha-labs-male-enhancement-gummies-claims-evaluated-the-alphalabs-ed-gummy-for-men-under-investigation Nepal Healthcare Times en PressRelease 2026-04-25T00:37:11+00:00 Alpha Labs Male Enhancement Gummies Claims Evaluated: The AlphaLabs ED Gummy for Men Under Investigation https://zingfast.com/wp-content/uploads/2026/04/Alpha-Labs-Male-Enhancement-Gummies.jpg https://nepalhealthcaretimes.com/article/907891379-performance-lab-under-investigation-premium-grade-nutritional-supplements-with-research-backed-ingredients-that-work Nepal Healthcare Times en PressRelease 2026-04-24T21:46:40+00:00 Performance Lab Under Investigation: Premium-Grade Nutritional Supplements with Research-Backed Ingredients That Work https://zingfast.com/wp-content/uploads/2026/04/Performance-Lab-Supplements.jpg https://nepalhealthcaretimes.com/article/907862916-ultragenyx-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Nepal Healthcare Times en PressRelease 2026-04-24T20:30:00+00:00 Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/121a9bda-7a64-41f8-85e8-1693a2dfa977/small/ultragenyx-cmyk-png.png https://nepalhealthcaretimes.com/article/907863572-park-dental-partners-announces-dates-for-first-quarter-2026-earnings-release-and-conference-call Nepal Healthcare Times en PressRelease 2026-04-24T20:16:00+00:00 Park Dental Partners Announces Dates for First Quarter 2026 Earnings Release and Conference Call https://ml.globenewswire.com/media/48fd5730-f848-4991-96db-3d4db3274d34/small/pdp-rgb-jpg.jpg https://nepalhealthcaretimes.com/article/907863254-crescent-biopharma-announces-grants-of-inducement-awards Nepal Healthcare Times en PressRelease 2026-04-24T20:15:00+00:00 Crescent Biopharma Announces Grants of Inducement Awards https://ml.globenewswire.com/media/57dabf2a-90a3-4786-9c39-d1e71cc7707f/small/crescent-biopharma-logo-color-png.png https://nepalhealthcaretimes.com/article/907862990-aeon-biopharma-sets-annual-shareholder-meeting Nepal Healthcare Times en PressRelease 2026-04-24T20:05:00+00:00 AEON Biopharma Sets Annual Shareholder Meeting https://ml.globenewswire.com/media/c49be6f2-5e65-4a6d-9aef-e6b695554fb6/small/aeon-logo-png.png https://nepalhealthcaretimes.com/article/907863974-intellia-therapeutics-to-report-topline-data-from-global-phase-3-haelo-clinical-trial-of-lonvoguran-ziclumeran-in-hereditary-angioedema-on-april-27 Nepal Healthcare Times en PressRelease 2026-04-24T20:05:00+00:00 Intellia Therapeutics to Report Topline Data from Global Phase 3 HAELO Clinical Trial of Lonvoguran Ziclumeran in Hereditary Angioedema on April 27, 2026 https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://nepalhealthcaretimes.com/article/907863052-compass-therapeutics-to-announce-topline-secondary-endpoints-from-the-phase-2-3-companion-002-study-of-tovecimig-in-patients-with-biliary-tract-cancer Nepal Healthcare Times en PressRelease 2026-04-24T20:00:00+00:00 Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer https://ml.globenewswire.com/media/b8470129-5d30-4368-8074-d77404b65be8/small/compass-logo-rgb-outlines-png.png https://nepalhealthcaretimes.com/article/907864345-fda-accelerates-action-on-treatments-for-serious-mental-illness-following-executive-order Nepal Healthcare Times en PressRelease 2026-04-24T19:58:44+00:00 FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order https://ml.globenewswire.com/media/MWQ3ODlmMmYtNjY3OC00YThmLTljNGEtZGM4Y2I3NDcxMDMzLTUwMDE1NDE1NC0yMDI2LTA0LTI0LWVu/tiny/FDA.png https://nepalhealthcaretimes.com/article/907834419-delaware-chancery-court-rules-in-favor-of-anaptys-by-dismissing-tesaro-s-anticipatory-breach-claim Nepal Healthcare Times en PressRelease 2026-04-24T19:40:00+00:00 Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png https://nepalhealthcaretimes.com/article/907833308-forlife-and-oakmed-ltd-to-become-unora-gmbh-and-unora-healthcare-ltd-effective-may-1-2026 Nepal Healthcare Times en PressRelease 2026-04-24T19:00:00+00:00 ForLife and Oakmed Ltd. to Become Unora GmbH and Unora Healthcare Ltd Effective May 1, 2026 https://ml-eu.globenewswire.com/media/ZTBmOWRlZTUtZjE4MC00NDBlLWJiZDMtMzkzNWU2OTFhYWU2LTEzMjI5MzAtMjAyNi0wNC0yNC1lbg==/tiny/ForLife.png https://nepalhealthcaretimes.com/article/907833851-biotech-startup-plopii-files-us-patent-on-the-next-generation-headache-pill Nepal Healthcare Times en PressRelease 2026-04-24T18:32:58+00:00 Biotech startup Plopii Files US Patent on the Next-Generation Headache Pill https://ml.globenewswire.com/media/739b4d63-30b2-44c2-ab95-2446ee5dc3bf/medium/plopii-headache-pill.jpg https://nepalhealthcaretimes.com/article/907833353-press-release-sanofi-successfully-prices-2-3-billion-of-bond-issue Nepal Healthcare Times en PressRelease 2026-04-24T18:30:00+00:00 Press Release: Sanofi successfully prices 2.3 billion of bond issue https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://nepalhealthcaretimes.com/article/907833358-communiqu-de-presse-sanofi-place-2-3-milliard-d-euros-d-emprunts-obligataires Nepal Healthcare Times en PressRelease 2026-04-24T18:30:00+00:00 Communiqué de presse : Sanofi place 2,3 milliard d’euros d’emprunts obligataires https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://nepalhealthcaretimes.com/article/907800388-rta-outdoor-living-launches-health-haven-youtube-special-on-backyard-design-and-health Nepal Healthcare Times en PressRelease 2026-04-24T17:10:00+00:00 RTA Outdoor Living Launches 'Health Haven' YouTube Special on Backyard Design and Health https://pressranger.s3.us-west-1.amazonaws.com/3235413/RTA-Health-Haven.jpg